Bio-Path Holdings Files 8-K
Ticker: BPTH · Form: 8-K · Filed: Dec 12, 2024 · CIK: 1133818
| Field | Detail |
|---|---|
| Company | Bio-Path Holdings, Inc. (BPTH) |
| Form Type | 8-K |
| Filed Date | Dec 12, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC filing, Regulation FD
Related Tickers: BPTH
TL;DR
BPTH filed an 8-K, check for material updates.
AI Summary
Bio-Path Holdings, Inc. filed an 8-K on December 12, 2024, reporting an event on December 11, 2024. The filing is a current report under Regulation FD and includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Bellaire, Texas.
Why It Matters
This 8-K filing indicates a material event has occurred for Bio-Path Holdings, Inc., requiring public disclosure under SEC regulations.
Risk Assessment
Risk Level: low — This filing is a standard 8-K current report and does not inherently indicate significant new risks.
Key Players & Entities
- BIO-PATH HOLDINGS, INC. (company) — Registrant
- December 11, 2024 (date) — Earliest event reported
- December 12, 2024 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Bellaire, Texas (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Bio-Path Holdings, Inc.?
The primary purpose is to serve as a current report under Section 13 or 15(d) of the Securities Exchange Act of 1934, disclosing a material event that occurred on December 11, 2024.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on December 12, 2024.
What information is indicated to be included in this filing besides the report itself?
The filing indicates it includes financial statements and exhibits.
Where are Bio-Path Holdings, Inc.'s principal executive offices located?
The principal executive offices of Bio-Path Holdings, Inc. are located at 4710 Bellaire Boulevard, Suite 210, Bellaire, Texas 77401.
What is the state of incorporation for Bio-Path Holdings, Inc.?
Bio-Path Holdings, Inc. is incorporated in Delaware.
Filing Stats: 439 words · 2 min read · ~1 pages · Grade level 10.8 · Accepted 2024-12-12 16:15:37
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share BPTH The Nasdaq Capital M
Filing Documents
- bpth-20241211x8k.htm (8-K) — 39KB
- bpth-20241211xex99d1.htm (EX-99.1) — 27KB
- bpth-20241211xex99d1001.jpg (GRAPHIC) — 11KB
- 0001558370-24-016182.txt ( ) — 206KB
- bpth-20241211.xsd (EX-101.SCH) — 3KB
- bpth-20241211_lab.xml (EX-101.LAB) — 16KB
- bpth-20241211_pre.xml (EX-101.PRE) — 10KB
- bpth-20241211x8k_htm.xml (XML) — 5KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On December 11, 2024, Bio-Path Holdings, Inc. (the "Company") issued a press release titled, "Bio-Path Holdings Outlines Rationale for Development of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients." A copy of such press release is attached hereto as Exhibit 99.1.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits . Exhibit Number Description 99.1 Press release dated December 11, 2024. 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL (included as Exhibit 101).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-PATH HOLDINGS, INC. Dated: December 11, 2024 By: /s/ Peter H. Nielsen Peter H. Nielsen President and Chief Executive Officer